BID | 113.02 | ASK | 113.13 | ||
Open | 114.20 | Previous Close | 114.56 | ||
Pre-Market | - | After-Market | - | ||
- -% | - - |
Target Price | 122.38 | Analyst Rating | Strong Buy 1.13 | |
Potential % | 8.10 | Finscreener Ranking | ★★ 47.12 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★+ 45.89 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★+ 51.56 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★ 35.29 | |
Market Cap | 7.50B | Earnings Rating | Strong Buy | |
Price Range Ratio 52W % | 87.64 | Earnings Date | 30th Apr 2021 |
Today's Price Range 112.95114.86 | 52W Range 80.31117.68 | 5 Year PE Ratio Range 21.9075.80 |
Summary:
Buy
Technical Indicators: | Buy |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 1.43% | ||
1 Month | 4.30% | ||
3 Months | 14.67% | ||
6 Months | 27.96% | ||
1 Year | 0.31% | ||
3 Years | 30.43% | ||
5 Years | 114.57% | ||
10 Years | 200.91% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 12.18 | |||
ROE last 12 Months | 13.73 | |||
ROA (5Y Avg) | 3.94 | |||
ROA last 12 Months | 5.06 | |||
ROC (5Y Avg) | 6.74 | |||
ROC last 12 Months | 8.29 | |||
Return on invested Capital Q | 2.03 | |||
Return on invested Capital Y | 7.45 | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 3.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
30.80 | ||||
4.19 | ||||
3.36 | ||||
14.80 | ||||
26.60 | ||||
7.52 | ||||
-7.08 | ||||
26.57 | ||||
8.96B | ||||
Forward PE | 17.72 | |||
PEG | 4.22 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.00 | ||||
1.50 | ||||
0.48 | ||||
1.06 | ||||
5.10 | ||||
Leverage Ratio | 2.70 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
51.50 | ||||
12.70 | ||||
18.80 | ||||
7.10 | ||||
8.94 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.21B | ||||
33.36 | ||||
-1.78 | ||||
2.18 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.86 | ||||
0.96 | ||||
5.81 | ||||
6.46 | ||||
Payout ratio | 26.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2021 | 1.05 | 1.53 | 45.71 |
Q04 2020 | 1.08 | 1.17 | 8.33 |
Q03 2020 | 1.44 | 1.95 | 35.42 |
Q02 2020 | 1.14 | 1.28 | 12.28 |
Q01 2020 | 1.08 | 1.13 | 4.63 |
Q04 2019 | 1.65 | 1.69 | 2.42 |
Q03 2019 | 1.21 | 1.23 | 1.65 |
Q02 2019 | 1.11 | 1.14 | 2.70 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | 1.43 | 11.72 | Positive |
6/2021 QR | 1.34 | -1.47 | Negative |
9/2021 FY | 5.80 | 8.21 | Positive |
9/2022 FY | 6.37 | 3.58 | Positive |
Next Report Date | 30th Apr 2021 |
Estimated EPS Next Report | 1.43 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | 7.30 |
Volume Overview | |
---|---|
Volume | 151.94K |
Shares Outstanding | 66.36M |
Trades Count | 3.15K |
Dollar Volume | 34.52M |
Avg. Volume | 440.19K |
Avg. Weekly Volume | 233.51K |
Avg. Monthly Volume | 321.98K |
Avg. Quarterly Volume | 448.35K |
Hill-Rom Holdings Inc (NYSE: HRC) stock closed at 114.56 per share at the end of the most recent trading day (a 0.46% change compared to the prior day closing price) with a volume of 365.91K shares and market capitalization of 7.50B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 10000 people. Hill-Rom Holdings Inc CEO is John P. Groetelaars.
The one-year performance of Hill-Rom Holdings Inc stock is 0.31%, while year-to-date (YTD) performance is 16.93%. HRC stock has a five-year performance of 114.57%. Its 52-week range is between 80.31 and 117.68, which gives HRC stock a 52-week price range ratio of 87.64%
Hill-Rom Holdings Inc currently has a PE ratio of 30.80, a price-to-book (PB) ratio of 4.19, a price-to-sale (PS) ratio of 3.36, a price to cashflow ratio of 14.80, a PEG ratio of 2.32, a ROA of 5.06%, a ROC of 8.29% and a ROE of 13.73%. The company’s profit margin is 8.94%, its EBITDA margin is 18.80%, and its revenue ttm is $2.21 Billion , which makes it $33.36 revenue per share.
Of the last four earnings reports from Hill-Rom Holdings Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.43 for the next earnings report. Hill-Rom Holdings Inc’s next earnings report date is 30th Apr 2021.
The consensus rating of Wall Street analysts for Hill-Rom Holdings Inc is Strong Buy (1.13), with a target price of $122.38, which is +8.10% compared to the current price. The earnings rating for Hill-Rom Holdings Inc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Hill-Rom Holdings Inc has a dividend yield of 0.86% with a dividend per share of $0.96 and a payout ratio of 26.00%.
Hill-Rom Holdings Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 9.54, ATR14 : 2.64, CCI20 : 161.70, Chaikin Money Flow : -0.01, MACD : 2.66, Money Flow Index : 77.69, ROC : 3.91, RSI : 55.93, STOCH (14,3) : 82.90, STOCH RSI : 1.00, UO : 58.08, Williams %R : -17.10), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Hill-Rom Holdings Inc in the last 12-months were: Amy M. Dodrill (Option Excercise at a value of $158 134), Andreas G. Frank (Option Excercise at a value of $628 765), Andreas G. Frank (Sold 22 000 shares of value $1 970 815 ), Barbara W. Bodem (Option Excercise at a value of $122 273), Deborah M. Rasin (Option Excercise at a value of $1 098 794), Deborah M. Rasin (Sold 8 817 shares of value $906 476 ), John P. Groetelaars (Option Excercise at a value of $2 342 367), Kenneth F. Meyers (Option Excercise at a value of $780 216), Mary Kay Ladone (Option Excercise at a value of $640 976), Mary Kay Ladone (Sold 5 403 shares of value $581 830 ), Paul Sherwood Johnson (Option Excercise at a value of $1 623 033), Paul Sherwood Johnson (Sold 21 919 shares of value $2 360 541 ), Richard M. Wagner (Option Excercise at a value of $248 957)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.
CEO: John P. Groetelaars
Telephone: +1 312 819-7200
Address: 130 East Randolph Street, Chicago 60601, IL, US
Number of employees: 10 000
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.